Gross profit · 2020–2023
Emergent Biosolutions gross profit
$318M−17.1% · FY2023
Emergent Biosolutions (EBS) reported $318M in gross profit for fiscal 2023, −17.1% year on year.
Gross profit — Gross profit is revenue minus the direct cost of goods and services sold. Not every company reports it; those that do not are absent from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2020–2023 compound annual growth −30.0%
Gross profit at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Emergent Biosolutions gross profit |url=https://companiesranked.com/en/company/emergent-biosolutions/gross-profit |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Emergent Biosolutions gross profit. CompaniesRanked. https://companiesranked.com/en/company/emergent-biosolutions/gross-profitBibTeX
@misc{companiesranked-en-company-emergent-biosolutions-gross-profit-2026,
author = {{CompaniesRanked}},
title = {{Emergent Biosolutions gross profit}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/emergent-biosolutions/gross-profit}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.